Table 3.
Demographic and clinical features of LTRs with SARS-CoV2 infection: comparison between symptomatic and asymptomatic. LT: liver transplant, HCC: hepatocellular carcinoma, BMI: body mass index, GFR: glomerular filtrate rate, MMF: mycophenolate mofetil. Evaluated comorbidities*: diabetes mellitus, obesity, GFR <50 ml/min, cardiopathy, active smoking, chronic obstructive pulmonary disease.
| Variable | Symptomatic SARS-CoV2 infections (N = 12) | Asymptomatic SARS-CoV2 infections (N = 19) | p |
|---|---|---|---|
| Male Gender | 7 (58.3%) | 18 (94.7%) | 0.022 |
| Age >60 years | 5 (41.7%) | 14 (73.7%) | 0.13 |
| Years from LT ≥5 | 6 (50%) | 15 (78.9%) | 0.13 |
| Diabetes mellitus | 4 (33.3%) | 10 (52.6%) | 0.46 |
| Obesity (BMI>30 Kg/m2) | 2 (16.7%) | 5 (26.3%) | 0.68 |
| GFR <50 ml/min | 6 (50%) | 1 (5.2%) | 0.007 |
| Comorbidities* (≥3) | 4 (33.3%) | 4 (21.1%) | 0.66 |
| Current MMF | 9 (75%) | 8 (42.1%) | 0.14 |